New Strategies For Tackling Triple-Negative Breast Cancer
Research at JAX has uncovered a molecular “fingerprint” that could lead to better outcomes for TNBC patients. JAX Associate Research Scientist Francesca Menghi wants oncologists to have a much larger array of therapies available for their triple-negative breast cancer patients.
![](https://scottrmackenziefoundation.com/wp-content/uploads/2021/04/Jax-labs-SRMF-10-1024x662.jpg)